Yang Xiaofeng
Cell Therapy Center, Chinese PLA 463 Hospital, Shenyang 110042, Liaoning Province, China.
Neural Regen Res. 2012 Aug 5;7(22):1744-51. doi: 10.3969/j.issn.1673-5374.2012.22.010.
To identify global research trends in stem cell transplantation for treating Duchenne muscular dystrophy using a bibliometric analysis of Web of Science.
We performed a bibliometric analysis of studies on stem cell transplantation for treating Duchenne muscular dystrophy from 2002 to 2011 retrieved from Web of Science.
(a) peer-reviewed published articles on stem cell transplantation for treating Duchenne muscular dystrophy indexed in Web of Science; (b) original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material, and news items; and (c) publication between 2002 and 2011.
(a) articles that required manual searching or telephone access; (b) documents that were not published in the public domain; and (c) corrected papers.
(1) Annual publication output; (2) distribution according to subject areas; (3) distribution according to journals; (4) distribution according to country; (5) distribution according to institution; (6) distribution according to institution in China; (7) distribution according to institution that cooperated with Chinese institutions; (8) top-cited articles from 2002 to 2006; (9) top-cited articles from 2007 to 2011.
A total of 318 publications on stem cell transplantation for treating Duchenne muscular dystrophy were retrieved from Web of Science from 2002 to 2011, of which almost half derived from American authors and institutes. The number of publications has gradually increased over the past 10 years. Most papers appeared in journals with a focus on gene and molecular research, such as Molecular Therapy, Neuromuscular Disorders, and PLoS One. The 10 most-cited papers from 2002 to 2006 were mostly about different kinds of stem cell transplantation for muscle regeneration, while the 10 most-cited papers from 2007 to 2011 were mostly about new techniques of stem cell transplantation for treating Duchenne muscular dystrophy.
The publications on stem cell transplantation for treating Duchenne muscular dystrophy were relatively few. It also needs more research to confirm that stem cell therapy is a reliable treatment for Duchenne muscular dystrophy.
通过对科学网进行文献计量分析，确定治疗杜氏肌营养不良症的干细胞移植的全球研究趋势。
我们对2002年至2011年从科学网检索到的关于治疗杜氏肌营养不良症的干细胞移植研究进行了文献计量分析。
(a) 在科学网中索引的关于治疗杜氏肌营养不良症的干细胞移植的同行评审发表文章；(b) 原创研究文章、综述、会议摘要、会议论文、书籍章节、编辑材料和新闻报道；以及(c) 2002年至2011年期间的出版物。
(a) 需要手动搜索或电话访问的文章；(b) 未在公共领域发表的文献；以及(c) 更正后的论文。
(1) 年度发表量；(2) 按学科领域分布；(3) 按期刊分布；(4)按国家分布；(5) 按机构分布；(6) 在中国的机构分布；(7) 与中国机构合作的机构分布；(8) 2002年至2006年被引用次数最多的文章；(9) 2007年至2011年被引用次数最多的文章。
2002年至2011年从科学网共检索到318篇关于治疗杜氏肌营养不良症的干细胞移植的出版物，其中近一半来自美国作者和机构。在过去10年中，出版物数量逐渐增加。大多数论文发表在专注于基因和分子研究的期刊上，如《分子治疗》《神经肌肉疾病》和《公共科学图书馆·综合》。2002年至2006年被引用次数最多的10篇论文大多是关于不同类型的干细胞移植用于肌肉再生，而2007年至2011年被引用次数最多的10篇论文大多是关于治疗杜氏肌营养不良症的干细胞移植新技术。
关于治疗杜氏肌营养不良症的干细胞移植的出版物相对较少。还需要更多研究来证实干细胞疗法是治疗杜氏肌营养不良症的可靠方法。
